Search CHA Search
 
  
Home    Site Map
Site Map
Site Map
About CHA
Our Mission 
Strategic Business Planning 
Innovation Acceleration Services 
CHA Collaborative Projects 
Management Team 
Charlie Hoban, Chief Executive Officer 
Eugene Williams, Founder, Strategic Advisor 
Andrew Branca, SVP, Strategic Research 
Ernie Bush, Ph.D., VP & Scientific Director (formerly F. Hoffman-La Roche) 
Eric Glazer, VP, Marketing 
Eric Meyers, VP, Global Initiatives 
Frank Attardo, Project Director (formerly Hewlett Packard) 
Haizhou Zhang, Ph.D., VP, China Operations (formerly Boehringer Ingelheim) 
Guido Grentzmann, Ph.D. (formerly with Altana) 
Jack A. Reynolds, D.V.M. (formerly with Pfizer) 
Ellen Sheehy 
John Donovan (formerly Wyeth) 
Careers 
About Collaborative Projects
Current Collaborative Projects - Enrollment Open 
Evaluating Preclinical Cardio-Toxicity Assessment Tools 
Leveraging Biomarker & Translational Research in China 
Assessing GLP Compliance and Quality Practices in China 
Exploiting Legacy Safety Studies 
Assessing the Asian Supply Chain of Non-Human Primates (NHPs) 
Case Studies of Past CHA Projects 
Conducting Preclinical Safety Studies in China 
Consensus Protocol for Human Sample Collection 
Toxicokinetics (TK) Optimization 
Events
On Demand Webinar: Emerging Impact of Zebrafish Technology on Preclinical Safety Decision Making 
On Demand Webinar: The Impact of the Covance-WuXi Joint Venture 
On-Demand Webinar: The Adoption of Novel Technologies in the Preclinical R&D Process 
On Demand Webinar: Collaborating to Improve R&D Economics - A Call to Action 
On Demand Webinar: Strategies for Leveraging Preclinical Capabilities in China -June 24 @ 8:00 AM 
On Demand Webinar: Strategies for Leveraging Preclinical Capabilities in China -June 24 @ 2:00 PM 
Research
Animal Sourcing in China: Benchmarking Study 
In Vitro Cardiotoxicity Assessment: Benchmarking Study 
Contact Us
Directions 
Contact Us 
Site Map
Privacy Policy
Terms of Use
Search